Ashish Sarraju @AshishSarraju

Cardiologist @ClevelandClinic @CleClinicHVTI | Alum @StanCVFellows @Stanfordmedres | Preventive Cardiology, Digital Health | tweets own opinions Cleveland, OH Joined May 2017

Tweets

222
Followers

622
Following

370
Likes

1K

Gabor Toth, MD @GaborTothMD

3 months ago

Carotid web? Novel agents for stroke prevention? Interesting case discussions? We got it all covered at @CleClinicMD Cerebrovascular Center Innovations in Cerebrovascular Care Conference 2025! ccfcme.org/iicc Thank you to our presenters @MariaSokolaMD @AshishSarraju

1 5 17 650 1

Download Image

The Lancet @TheLancet

4 months ago

Atherosclerotic cardiovascular disease contributes substantially to the global burden of cardiovascular disease. A new trial suggests promise for broadening the therapeutic landscape for patients with pre-existing or high risk for ASCVD. Find out more: hubs.li/Q03mW6MF0

2 22 97 58K 20

Download Image

American College of Cardiology @ACCinTouch

4 months ago

The BROADWAY trial assesses the safety and efficacy of obicetrapib among patients at high risk for cardiovascular events. Get more details ➡️ bit.ly/4mmYQx6 #CardioX

0 8 16 3K 0

Cleveland Clinic Heart, Vascular & Thoracic @CleClinicHVTI

4 months ago

Lowering your LDL cholesterol can be crucial for managing heart disease. A new drug combination lowered it by nearly half in a new clinical trial. @AshishSarraju explains the findings. Read more: cle.clinic/434bvMm

2 4 15 2K 0

Download Video

Federica Fogacci @FedericaFogacci

4 months ago

The results of the TANDEM trial have been published in The Lancet @TheLancet, simultaneously with their presentation at the #EASCongress2025! Read the full article here: doi.org/10.1016/S0140-… @AshishSarraju @ProfSNicholls @JohnKastelein @EASCongress @society_eas

0 4 17 496 0

Download Image

Luke J. Laffin @ljlaffin

4 months ago

Congratulations to my friend and colleague, @AshishSarraju , and the team at C5Research (@CleClinicHVTI ) on completing and publishing the TANDEM trial demonstrating the lipid lowering efficacy of obicetrapib-ezetimibe FDC thelancet.com/journals/lance…

1 5 34 2K 0

Cardiology Today @CardiologyToday

4 months ago

🚨Breaking news from #EASCongress2025 🚨 Obicetrapib/ezetimibe combo therapy nearly halved LDL at 84 days for patients with ASCVD or at high risk for it already taking maximally tolerated lipid-lowering therapy. @EASCongress @AshishSarraju #cardiology healio.com/news/cardiolog…

0 3 6 673 0

Eric Topol @EricTopol

4 months ago

And a randomized trial @TheLancet with this CETP drug and ezetimibe combination thelancet.com/journals/lance…

2 12 34 14K 5

Download Image

Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 @pabeda1

4 months ago

Two late-breaker clinical trials on Obicetrapib presented today at @EASCongress. 1st, by Steven Nissen. Note that this study evaluates a fixed-dose combination of obicetrapib/ezetimibe in pts treated with maximally tolerated doses of statins. #EASCongress2025 @JohnKastelein

1 5 17 931 1

Download Image

Steve Nicholls @ProfSNicholls

4 months ago

Exciting day with more obicetrapib data for at ⁦⁦@society_eas⁩ with publications in ⁦@NEJM⁩ and ⁦@TheLancet⁩ ⁦@JohnKastelein⁩ ⁦@ProfKausikRay⁩ ⁦@mdavidsonmd⁩ ⁦@ajnelson⁩ ⁦@julie_butters⁩ ⁦@MonashVHI⁩ ⁦@NewAmsPharma⁩

2 27 106 15K 10

Download Image

Sneha Shah Jain, MD, MBA @SnehaShahJain

9 months ago

1/ Now in @JACCJournals: The Coming AI Revolution in Clinical Trials. @euanashley @drnigam @AshishSarraju @kevin_schulman @HeartBobH @TheMahaf sciencedirect.com/science/articl… #JACC @StanfordMed @StanfordDeptMed @SCCR_Stanford

1 8 19 4K 2

David Ouyang, MD @David_Ouyang

11 months ago

1/n We are excited to announce EchoPrime – the first echocardiography AI model capable of evaluating a full transthoracic echocardiogram study, identify the most relevant videos, and produce a comprehensive interpretation! Great work lead by @milos_ai, EchoPrime is the largest…

26 157 455 112K 172

Download Video

Ashish Sarraju @AshishSarraju

11 months ago

Grateful to Jennifer sharing her journey with the diagnosis of FH. More work awaits to improve awareness, diagnosis, and management. Resources from the @FamilyHeartFdn are invaluable! #FHawarenessday @joshuawknowles @FaRodriguezMD @CleClinicHVTI @tavrkapadia

ClevelandClinicNews @CleClinicNews

12 months ago

0 5 8 2K 0

0 0 11 1K 0

ClevelandClinicNews @CleClinicNews

12 months ago

Jennifer's LDL cholesterol was more than three times the normal range. It's known as "bad" cholesterol because it can block arteries in the heart. Jennifer has a genetic condition called FH. Now she's using her diagnosis to help others. #FHAwarenessDay bit.ly/47DD40S

0 5 8 2K 0

Eric Topol @EricTopol

a year ago

Aspirin for primary prevention of cardiovascular disease has been shown to cause more bleeding than benefit in randomized trials over the past 5 years. But it's still being taken by 1 of 3 older Americans. acpjournals.org/doi/full/10.73… @AnnalsofIM @MohakGuptaMD @AshishSarraju

37 411 1K 149K 286

Download Image

Pradeep Natarajan @pnatarajanmd

2 years ago

.@AshishSarraju & S. Nissen discuss the evidence surrounding atherosclerotic plaque stabilization & regression as important clinical surrogates, and advancing therapeutic development nature.com/articles/s4156… @NatRevCardiol

5 24 108 11K 33

Download Image

Nature Reviews Cardiology @NatRevCardiol

2 years ago

Hot off the press! @AshishSarraju & Steven Nissen review the clinical evidence for atherosclerotic plaque stabilization and regression: rdcu.be/dvarz @CleClinicHVTI